¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"constitutive expression"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • affective expression
    Á¤µ¿Ç¥Çö
  • expression
    1. Ç¥Çö, ¹ßÇö 2. Ç¥Á¤ 3. À¯ÀüÀÚ¹ßÇö 4. Â¥±â
  • gene expression
    À¯ÀüÀÚ¹ßÇö
  • manual expression
    1. ¼ÕÁþÇ¥Çö, ¼Õ³î¸² 2. Á¥Â¥±â
  • phenotypic expression
    Ç¥ÇöÇü¹ßÇö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • expression
    Ç¥Çö, ¹ßÇö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • affective expression
    Á¤µ¿Ç¥Çö
  • expression
    Ç¥Çö, ¹ßÇö
  • gene expression
    À¯ÀüÀÚ¹ßÇö
  • manual expression
    ¼ÕÁþÇ¥Çö, ¼Õ³î¸²
  • phenotypic expression
    Ç¥ÇöÇü¹ßÇö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Constitutive endoeytosis
    ±¸¼º¼º ¼¼Æ÷³»ÀÌÀÔ(ϰà÷á¬øàÒ®ì¹ìý)
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£Ç¥Çö
  • affective expression
    Á¤µ¿Ç¥Çö
  • phenotypic expression
    Ç¥ÇöÇüÃâÇö.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • constitutive enzyme
    ±¸¼ºÈ¿¼Ò(ϰà÷ý£áÈ).
  • constitutive enzyme
    ±¸¼ºÀûÈ¿¼Ò (±âº»)
  • enzyme, constitutive
    ±âº»±¸¼ºÀûÈ¿¼Ò
  • affective expression
    Á¤µ¿Ç¥Çö
  • expression
    Ç¥Á¤(øúï×), Ç¥Çö.
  • expression of fetus
    žƾÐÃâ(÷Ãä®äâõó).
  • expression of placenta
    ŹݾÐÃâ(÷ÃÚïäâõó).
  • gene expression
    À¯ÀüÀÚ¹ßÇö
  • loosely linked gene expression
    ÇüÁú¹ßÇöÀÇ ¿¬°á¼ÒÈ­.
  • manual expression
    ¿ë¼öÇ¥Çö(¼ú)(¡­Ç¥Çö¼ú).
  • muscles of expression
    Ç¥Á¤±Ù(øúï×ÐÉ).
  • muscles of expression
    Ç¥Á¤±Ù
  • perfect square expression
    ¿ÏÀüÆò¹æ½Ä(èÇîïøÁÛ°ãÒ).
  • phenotypic expression
    Ç¥ÇöÇüÃâÇö.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • constitutive expression
    ±¸¼º¹ßÇö(ϰà÷Û¡úÞ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • expression vector
    ¹ßÇö (Û¡úÞ) º¤ÅÍ
  • gene expression
    À¯ÀüÀÚ ¹ßÇö(ë¶îîí­Û¡úÞ)
  • genetic expression
    À¯Àü ¹ßÇö(ë¶îîÛ¡úÞ)
  • mammalian expression vector
    Æ÷À¯µ¿¹°¹ßÇö(øÔêáÔÑÚªÛ¡úÞ) º¤ÅÍ
  • background constitutive synthesis
    ±âº» ±¸¼ºÇÕ¼º(ÐñÜâϰà÷ùêà÷)
  • constitutive enzyme
    ±¸¼ºÈ¿¼Ò(ϰà÷ý£áÈ)
  • constitutive gene
    ±¸¼ºÀ¯ÀüÀÚ(ϰà÷ë¶îîí­)
  • constitutive mutation
    ±¸¼ºº¯ÀÌ(ϰà÷ܨì¶)
  • constitutive secretory cell
    ±¸¼º¼º ºÐºñ¼¼Æ÷(ϰà÷àõÝÂÝôá¬øà)
  • constitutive synthesis
    ±¸¼º¼º ÇÕ¼º(ϰà÷àõùêà÷)
  • operator-constitutive mutant
    ÀÛµ¿ÀÚ±¸¼º º¯ÀÌü(íÂÔÑí­Ï°à÷ܨì¶ô÷)
  • regulator-constitutive mutant
    Á¶ÀýÀÚ ±¸¼º º¯ÀÌü(ðàï½íºÏ°à÷ܨì¶ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • expression
    Ç¥Á¤, Ç¥Çö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
CTU cardiac-thoracic unit; centigrade thermal unit; constitutive transcription unit
IVET in vivo expression technology
NGBE neuraminidase/beta-galactosidase expression
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BEVS Baculovirus Expression Vector System
ESAG expression site-associated gene
IVET In vivo expression technology
SAGE Serial Analysis of Gene Expression
STAXI State Trait Anger Expression Inventory
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Constitutive endoeytosis
    ±¸¼º¼º ¼¼Æ÷³» ÀÌÀÔ
  • constitutive mutation
    ±¸¼ºÀû µ¹¿¬º¯ÀÌ
  • expression
    Ç¥Á¤, Ç¥Çö
    À°Ã¼Àû, °¨Á¤Àû »óÅ¿¡ µû¶ó °áÁ¤µÇ´Â ¾ó±¼ÀÇ ¿Ü°ß.
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£ Ç¥Çö
  • manual expression
    ¿ë¼ö Ç¥Çö, ¿ë¼ö Ç¥Çö¼ú
  • muscle of facial expression
    ¾È¸é Ç¥Á¤ ±Ù
    ´«, ÄÚ, ÀÔ ÁÖÀ§¿¡ ÀÖ´Â ±ÙÀ°À» ¾È¸é Ç¥Á¤ ±ÙÀ̶ó Çϸç, Á¾·ù¿¡´Â ±¤°æ±Ù
  • phenotypic expression
    Ç¥ÇöÇü ÃâÇö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
constitutive Constantly present, whether there is demand or not. Thus some enzymes are constitutively produced, whereas others are inducible.
(18 Nov 1997)
constitutive enzyme <enzyme> An enzyme that is constantly produced by the cell regardless of the growth conditions.
Compare: induced enzyme.
(05 Mar 2000)
constitutive gene A gene which is continuously expressed without any regulation (transcription can be neither suppressed nor encouraged). These genes generally encode housekeeping functions and are expressed at low levels in all cells.
(09 Oct 1997)
constitutive heterochromatin <protein> Regions on chromosomes which are permanently condensed and genetically inactive in every cell in the body. The condensed portions are always in the same position on both homologous chromosomes. An example is the centromeres.
Compare: facultative heterochromatin.
(09 Oct 1997)
constitutive mutant An organism with a mutation in a regulatory gene, so that the genes which its flawed regulatory product are supposed to suppress become constitutive genes, or impossible to turn off. Thus, the products of the uncontrolled genes are produced to excess.
(09 Oct 1997)
ambisense expression strategy <molecular biology> The coding of viral proteins in both the sense (coding) and antisense (noncoding) strands of complementary mRNA, so that the viral proteins are produced no matter which strand gets translated.
(09 Oct 1997)
mammalian expression vector <molecular biology> A vector that will produce large amounts of eukaryotic protein taxonomy notwithstanding, and not necessarily a protein from a mammal.
(20 Mar 1998)
gene expression <molecular biology> The full use of the information in a gene via transcription and translation leading to production of a protein and hence the appearance of the phenotype determined by that gene. Gene expression is assumed to be controlled at various points in the sequence leading to protein synthesis and this control is thought to be the major determinant of cellular differentiation in eukaryotes.
(18 Nov 1997)
gene expression regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. These processes include gene activation and genetic induction.
(12 Dec 1998)
gene expression regulation, archaeal Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in archaea.
(12 Dec 1998)
gene expression regulation, bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.
(12 Dec 1998)
gene expression regulation, developmental Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.
(12 Dec 1998)
gene expression regulation, enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.
(12 Dec 1998)
gene expression regulation, fungal Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.
(12 Dec 1998)
gene expression regulation, leukaemic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukaemia.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • constitutive
    ±¸¼ºÀûÀÎ;±¸Á¶ÀÇ;±¸¼ººÐÀÇ;¿ä¼ÒÀÇ;Á¦Á¤(¼³Á¤)ÀûÀÎ;Á¦Á¤(¼³Á¤)±ÇÀÌ ÀÖ´Â;~ly
  • expression
    Ç¥Çö,¹ßÇ¥,Ç¥Á¤
  • expression
    Ç¥Çö;¸»Åõ;Ç¥Á¤
  • expression mark
    (¾Ç)³ªÅ¸³¿ ¸»;¹ß»ó±âÈ£
  • gene expression
    À¯ÀüÀÚ ¹ßÇö(À¯ÀüÀÚ Á¤º¸°¡ ƯÁ¤ ÇüÁú·Î¼­ ³ªÅ¸³ª±â)
  • self expression
    ÀÚ°¡Ç¥Çö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á